An analytical study of prostate-specific antigen dynamics
Summary: The purpose of this research is to carry out a quantitative study of prostate-specific antigen dynamics for patients with prostatic diseases, such as benign prostatic hyperplasia (BPH) and localized prostate cancer (LPC). The proposed PSA mathematical model was implemented using clinical data of 218 Japanese patients with histological proven BPH and 147 Japanese patients with LPC (stages T2a and T2b). For prostatic diseases (BPH and LPC) a nonlinear equation was obtained and solved in a close form to predict PSA progression with patients' age. The general solution describes PSA dynamics for patients with both diseases LPC and BPH. Particular solutions allow studying PSA dynamics for patients with BPH or LPC. Analytical solutions have been obtained and solved in a close form to develop nomograms for a better understanding of PSA dynamics in patients with BPH and LPC. This study may be useful to improve the diagnostic and prognosis of prostatic diseases.
- Modeling biomarker dynamics with implications for the treatment of prostate cancer
- Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
- A stochastic model for PSA levels: behavior of solutions and population statistics
- A stochastic model for prostate-specific antigen levels
- Prostate cancer: Progression of prostate-specific antigen after external beam irradiation
- A stochastic model for prostate-specific antigen levels
- Modeling biomarker dynamics with implications for the treatment of prostate cancer
- Modeling of the pH- and the temperature-dependant deviations of the free to total PSA (prostate specific antigen) ratios for clinical predictability of prostate cancer and benign prostate hyperplasia
This page was built for publication: An analytical study of prostate-specific antigen dynamics
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2011756)